![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hemogenyx Pharmaceuticals Plc | LSE:HEMO | London | Ordinary Share | GB00BYX3WZ24 | ORD GBP0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.026 | -1.79% | 1.425 | 1.402 | 1.448 | 1.42 | 1.41 | 1.42 | 3,614,132 | 16:35:13 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 0 | -6.69M | -0.0059 | -2.39 | 16.1M |
Date | Subject | Author | Discuss |
---|---|---|---|
01/3/2018 09:37 | Align - Not as bad as some..always DYor | ![]() tsmith2 | |
01/3/2018 09:36 | 10p easily here!!! | ![]() cudmore | |
01/3/2018 09:29 | I hate align with a passion but for once I'm benefiting from their ramp in this one today. Hard to sell and buy back cheaper mm's shut down limits quick to sell and buy when it suits them. Trend for now is higher highs | ![]() dave4545 | |
01/3/2018 09:25 | Second leg of 5 gearing up. | tidy 2 | |
01/3/2018 09:23 | I have to say I felt the RNS released was fantastic news and clearly the co got a bit over excited when someone tweeted when they shouldn't have.Need to remember this is not an AIM co either.In addition I liked the pro active interview and IMO a partner will see this rocket.I can wait for that day.Have to say PYC also will do the same once a second sizeable partner is announced and I believe they are way undervalued also. Could this be the year of the pharmas? | ![]() billthebank | |
01/3/2018 09:21 | Align's note will now be being received by folks who are on their emailing list. At the start of today it would have been only those who had been checking today's RNS's. f | ![]() fillipe | |
01/3/2018 09:18 | It should go up. Align, often put these out when they have taken a position and the shares go down. | ![]() ayesha4 | |
01/3/2018 09:15 | Shorts closing. Next leg up coming? | ![]() orchestralis | |
01/3/2018 09:13 | Tidy 2 going for gold | jimmyhoffa262 | |
01/3/2018 09:13 | Align are pumpers and dumpers led by Richie Rich. | ![]() ayesha4 | |
01/3/2018 09:06 | The Company is pleased to note the comments of Align in their research note ("Note") including its "conviction buy" stance and target price of 18.15 pence.Nice little RNS there. | tidy 2 | |
01/3/2018 08:56 | data results have shown that CDX bi-specific antibodies are capable of attacking and eliminating the blood cancer Acute Myelogenous Leukemia (AML) | tidy 2 | |
01/3/2018 08:47 | They are also now in the process of proving to several major pharma's that the cancer cure is a success in addition to proving that they also have humanised mice that can be used for numerous other drug testing. Sounds impressive. | tidy 2 | |
01/3/2018 08:42 | So the break through has the addition of humanised mice which can be used for purposes beyond proving their cancer cure works. | tidy 2 | |
01/3/2018 08:40 | Unlike at VAL no YA to deal with, warrants will bring in enough fully funded to 2019.Deals with large pharmas on horizon .. | ![]() tsmith2 | |
01/3/2018 08:37 | Broker has a target of 18p. That's without the news of the several major pharma's they're now working with. | tidy 2 | |
01/3/2018 08:32 | Shake over now you cannot buy online again | ![]() dave4545 | |
01/3/2018 08:28 | Already in talks and working close with SEVERAL major pharma's | tidy 2 | |
01/3/2018 08:28 | "data results have shown that CDX bi-specific antibodies are capable of attacking and eliminating the blood cancer Acute Myelogenous Leukemia (AML) in vitro. Using these new humanised mice the Company is confident that it should be able to demonstrate that its lead product, CDX bi-specific antibodies, are effective in the treatment of (AML). Use of the humanised mouse model should facilitate developing and progressing the CDX bi-specific antibodies into human trials, in line with the Company's development timeline." | tidy 2 | |
01/3/2018 08:21 | mm's are going to shake it big style. They will only let people sell online at a price that suits them and their profits. | ![]() dave4545 | |
01/3/2018 08:15 | im just saying it makes the company lookbad.tacky. some people are in for the long game ie 2-3 years and don't care about day to day little movements.... | ![]() moneytree1 | |
01/3/2018 08:12 | *stonking!! | ![]() tsmith2 | |
01/3/2018 08:12 | ps - I think VAL are a stinking buy too | ![]() tsmith2 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions